Allan Wu
Impact in
-
- Cancer Mechanisms and Therapy
-
- Synthesis and biological activity
- Quinazolinone synthesis and applications
- Synthesis and Characterization of Heterocyclic Compounds
Papers in
- Oncology 6
- Cytokine Signaling Pathways and Interactions 2
- Lung Cancer Research Studies 2
- Peptidase Inhibition and Analysis 2
- Colorectal Cancer Treatments and Studies 1
-
- Synthesis and biological activity 4
- Co-authors
- Les A. Dakin (5 shared papers)M. Block (3 shared papers)Michelle L. Lamb (4 shared papers)Paul D. Lyne (5 shared papers)Xiaolan Zheng (4 shared papers)Erika Krasnickas Keeton (3 shared papers)Isabelle Green (1 shared paper)Tina Howard (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (3 papers)Cancer Research (3 papers)Blood (1 paper)Journal of Chemical Information and Modeling (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United StatesSwedenUnited Kingdom
In The Last Decade
Allan Wu
8 papers receiving 130 citations
Peers
Comparison fields: 5 of 34
- Pathology and Forensic Medicine 83
- Organic Chemistry 61
- Oncology 49
- Molecular Biology 70
- Computational Theory and Mathematics 12
Countries citing papers authored by Allan Wu
This map shows the geographic impact of Allan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan Wu more than expected).
Fields of papers citing papers by Allan Wu
This network shows the impact of papers produced by Allan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan Wu. The network helps show where Allan Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Allan Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 85 | |
| 2 | 2018 | 10 | |
| 3 | 2022 | 9 | |
| 4 | 2023 | 8 | |
| 5 | 2011 | 8 | |
| 6 | 2008 | 7 | |
| 7 | 2013 | 5 | |
| 8 | 2012 | 3 | |
| 9 | 2012 | 0 |
About Allan Wu
Allan Wu is a scholar working on Oncology, Organic Chemistry, Pathology and Forensic Medicine, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 9 papers that have together received 135 indexed citations. Recurring topics across this work include Synthesis and biological activity (4 papers), Cancer Mechanisms and Therapy (4 papers), Cytokine Signaling Pathways and Interactions (2 papers), Lung Cancer Treatments and Mutations (2 papers), Lung Cancer Research Studies (2 papers), Peptidase Inhibition and Analysis (2 papers), Neuroblastoma Research and Treatments (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (83 citations), Organic Chemistry (61 citations), Oncology (49 citations), Molecular Biology (70 citations) and Computational Theory and Mathematics (12 citations). Allan Wu has collaborated with scholars based in United States, Sweden and United Kingdom. Frequent co-authors include Les A. Dakin, M. Block, Michelle L. Lamb, Paul D. Lyne, Xiaolan Zheng, Erika Krasnickas Keeton, Isabelle Green, Tina Howard, Xiaomei Feng and Tao Zhang. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Cancer Research, Blood, Journal of Chemical Information and Modeling and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.